Jun 2026 (Q2 FY26) — Jul 30, 2026
Merit Medical Systems Q2 FY26 — Strong Organic Growth and Profitability Exceed Expectations
Read the full callMerit Medical Systems (MMSI) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Merit Medical Systems earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 419 | +9.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 14.4 | +2.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 38.8 | +19.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$89.96 +0.85% · +$0.76
Performance +9.9% 1Y
1Y: $81.86 on 17 Oct 2025 → $89.96. High $93.18 (8 Jan 2026), low $60.31 (11 May 2026).
- Previous close
- $89.2
- 52-week range
- $60.31 – $93.18
- One year
- +8.11%
Overview
- Symbol
- MMSI
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — Apr 30, 2026
Merit Medical Q1 FY26 — Strong Start with Strategic Oncology Acquisition
Read the full callDec 2025 (Q4 FY25) — Feb 24, 2026
Merit Medical Systems Q4 FY25 — Record Gross Margin and Strong Free Cash Flow
Read the full callEvery analysed call
Merit Medical Systems earnings calls (MMSI)
Financials
What the filings say
Net profit, year on year: +19% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 340 | 355 | 355 | 382 | 384 | 394 | 382 | 419 |
| Operating profit | 37 | 37 | 41 | 47 | 43 | 54 | 44 | 60 |
| Operating margin | 11.0% | 10.3% | 11.6% | 12.3% | 11.1% | 13.8% | 11.6% | 14.4% |
| Other income | -1 | -3 | -3 | -4 | -4 | -3 | 9 | -9 |
| Interest | 8 | 8 | 7 | 7 | 7 | 6 | 7 | 12 |
| Profit before tax | 37 | 33 | 38 | 43 | 39 | 51 | 54 | 51 |
| Tax rate | 22.4% | 15.7% | 20.6% | 24.9% | 28.0% | 25.6% | 23.4% | 24.4% |
| Net profit | 28 | 28 | 30 | 33 | 28 | 38 | 41 | 39 |
| EPS ($ per share) | 0.49 | — | 0.51 | 0.55 | 0.47 | — | 0.69 | 0.65 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 571 | 587 | 606 | 642 | 675 | 638 | 703 | 764 |
| Reserves | 363 | 368 | 358 | 406 | 481 | 575 | 696 | 824 |
| Total liabilities | 687 | 807 | 706 | 608 | 520 | 1,123 | 1,039 | 1,102 |
| Fixed assets | 331 | 379 | 383 | 372 | 383 | 384 | 386 | 428 |
| Total assets | 1,620 | 1,757 | 1,664 | 1,648 | 1,664 | 2,325 | 2,419 | 2,686 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 87 | 78 | 165 | 147 | 114 | 145 | 221 | 297 |
| Cash from investing | -379 | -134 | -59 | -37 | -57 | -175 | -369 | -247 |
| Cash from financing | 328 | 34 | -96 | -98 | -60 | 559 | -60 | 16 |
| Net cash flow | 35 | -23 | 13 | 11 | -7 | 529 | -210 | 70 |
| Capital expenditure | -63 | -78 | -46 | -28 | -45 | -34 | -35 | -82 |
| Free cash flow | 23 | -0 | 119 | 119 | 69 | 111 | 186 | 216 |
MMSI revenue by segment
| Segment | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Single Reportable | — | — | — | — | — | — | 100% | 100% | — |
Share of consolidated revenue by quarter. Q4 is the fiscal year less its first three quarters.
See how segments are shifting across companies → Segment Shift
Revenue by region
Q2 FY2026 · share of revenue
- US 60% ↓ 1 pt
- Non Us 40% ↑ 1 pt
As MMSI cuts its regions in its filings; they can nest, so they need not add to 100%.
Insider filings
49 filings between Nov 18, 2025 and Sep 4, 2026.
Open market
decisions to buy or sellPurchases
$573.3K
5 purchases by 5 insiders
Sales
$8.45M
8 sales by 3 insiders
13% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 25
- Award — granted as compensation
- 3
- Option exercise — converted options into shares
- 5
- Tax withheld — shares kept back by the company to cover tax
Also filed: 3 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| LAMPROPOULOS FRED P | — | $5.19M | Nov 25, 2025 |
| Peterson Neil | — | $2.95M | Aug 24, 2026 |
| Ward Lynne N. | — | $313.0K | May 7, 2026 |
| Voigt Michel James | $136.5K | — | May 5, 2026 |
| Lloyd Brian G. | $125.3K | — | May 7, 2026 |
| Aronson Martha Goldberg | $120.9K | — | May 6, 2026 |
| Smith Christian Adam | $99.2K | — | May 11, 2026 |
| Parra Raul Jr. | $91.5K | — | May 6, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Lewis Sheri EVP of Global Operations | Award | 8,371 | $0 |
| Aug 24, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Gift | 650 | $0 |
| Aug 24, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Sale | 7,500 | $678.4K |
| Aug 4, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Sale | 21,449 | $1.82M |
| Jun 15, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Gift | 65 | $0 |
| Jun 5, 2026 | Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY | Gift | 2,000 | $0 |
| May 20, 2026 | Gunderson Thomas James Director | Option exercise | 7,500 | $391.3K |
| May 20, 2026 | Gunderson Thomas James Director | Option exercise | 13,750 | $717.3K |
| May 18, 2026 | Ward Lynne N. Director | Award | 3,457 | $0 |
| May 18, 2026 | Kaiser Laura S. Director | Award | 3,457 | $0 |
| May 18, 2026 | Gunderson Thomas James Director | Award | 3,457 | $0 |
| May 18, 2026 | Evans Stephen C. Director | Award | 3,457 | $0 |
| May 18, 2026 | Ward Scott R. Director | Award | 3,457 | $0 |
| May 18, 2026 | MCDONNELL MICHAEL R Director | Award | 3,457 | $0 |
| May 18, 2026 | Millner F. Ann Director | Award | 3,457 | $0 |
| May 18, 2026 | Carpenter Lonny J Director | Award | 3,457 | $0 |
| May 18, 2026 | Perez Silvia M. Director | Award | 3,457 | $0 |
| May 11, 2026 | Smith Christian Adam Chief Commercial Officer | Purchase | 1,626 | $99.2K |
| May 7, 2026 | Ward Lynne N. Director | Sale | 5,000 | $313.0K |
| May 7, 2026 | Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY | Purchase | 2,000 | $125.3K |
| May 6, 2026 | Parra Raul Jr. CFO AND TREASURER | Purchase | 1,500 | $91.5K |
| May 6, 2026 | Aronson Martha Goldberg President and CEO | Purchase | 2,000 | $120.9K |
| May 5, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Purchase | 2,250 | $136.5K |
| Feb 26, 2026 | Parra Raul Jr. CFO AND TREASURER | Award | 17,002 | $0 |
| Feb 26, 2026 | Parra Raul Jr. CFO AND TREASURER | Award | 9,613 | $0 |
| Feb 26, 2026 | Parra Raul Jr. CFO AND TREASURER | Award | 12,305 | $0 |
| Feb 26, 2026 | Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY | Tax withheld | 5,778 | $450.8K |
| Feb 26, 2026 | Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY | Award | 17,002 | $0 |
| Feb 26, 2026 | Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY | Award | 10,254 | $0 |
| Feb 26, 2026 | Parra Raul Jr. CFO AND TREASURER | Tax withheld | 5,778 | $450.8K |
| Feb 26, 2026 | Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY | Award | 6,409 | $0 |
| Feb 26, 2026 | Aronson Martha Goldberg President and CEO | Award | 28,198 | $0 |
| Feb 26, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Award | 7,690 | $0 |
| Feb 26, 2026 | Smith Christian Adam Chief Commercial Officer | Tax withheld | 2,018 | $157.4K |
| Feb 26, 2026 | Smith Christian Adam Chief Commercial Officer | Award | 6,762 | $0 |
| Feb 26, 2026 | Smith Christian Adam Chief Commercial Officer | Award | 6,409 | $0 |
| Feb 26, 2026 | Smith Christian Adam Chief Commercial Officer | Award | 8,203 | $0 |
| Feb 26, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Tax withheld | 6,061 | $472.9K |
| Feb 26, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Award | 17,002 | $0 |
| Feb 26, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Award | 7,690 | $0 |
| Feb 26, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Tax withheld | 6,698 | $522.6K |
| Feb 26, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Award | 17,002 | $0 |
| Feb 26, 2026 | Voigt Michel James CHIEF HUMAN RESOURCES OFFICER | Award | 6,409 | $0 |
| Jan 6, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Sale 10b5-1 plan | 5,000 | $450.0K |
| Jan 6, 2026 | Peterson Neil CHIEF OPERATING OFFICER | Option exercise 10b5-1 plan | 5,000 | $272.0K |
| Nov 25, 2025 | LAMPROPOULOS FRED P Executive Chairman | Sale | 10,000 | $880.4K |
| Nov 21, 2025 | LAMPROPOULOS FRED P Executive Chairman | Sale | 25,000 | $2.18M |
| Nov 20, 2025 | LAMPROPOULOS FRED P Executive Chairman | Sale | 20,000 | $1.70M |
| Nov 18, 2025 | LAMPROPOULOS FRED P Executive Chairman | Sale | 5,000 | $424.1K |
| Oct 3, 2025 | Aronson Martha Goldberg President and CEO | Award | 19,594 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for MERIT MEDICAL SYSTEMS INC
Free account. Everything above stays public.
Write why you follow MERIT MEDICAL SYSTEMS INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading